TransThera Sciences (Nanjing) stock came into this earnings print bruised, with the 90 day return deep in the red despite a small bounce over the past week and month. Yet the latest H1 2026 numbers ...
Source LinkTransThera Sciences (Nanjing) stock came into this earnings print bruised, with the 90 day return deep in the red despite a small bounce over the past week and month. Yet the latest H1 2026 numbers ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.